New clinical application prospects of artemisinin and its derivatives: a scoping review
Yangmu Huang, Yang Yang, Guangqi Liu, Ming Xu · 2023
Read New clinical application prospects of artemisinin and its derivatives: a scoping review by Yangmu Huang, Yang Yang, Guangqi Liu, Ming Xu (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10712159.txt.
Description
Yangmu Huang and co-authors published this scoping review in 2023 on artemisinin, the famed malaria drug drawn from a Chinese herb. Work hints the drug and its kin may also fight parasites, viruses, tumors, swelling, and skin ills. The team swept many data banks for clinical studies beyond malaria, in English and Chinese, up to late 2021. Seventy-seven studies made the cut.
Parasite studies led the count, with tumor, swelling, virus, and skin work behind. Most studies ran in Asia, then Africa. Virus work lagged, stuck mostly in early safety trials. Side effects were mild in nearly all reports, with one study noting a harsh event. Gains showed for most uses, though combo therapy for non-malaria parasites stayed in dispute. The authors map where proof is strong and where trials should go next.
Catalog record
| CREATOR | Yangmu Huang, Yang Yang, Guangqi Liu, Ming Xu |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |